NWI Management’s Verona Pharma VRNA Stock Holding History

NWI Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-135,000	Closed	-$14.4M	–	70
2025 Q3	$14.4M	Hold	135,000	–	–	0.77%	30
2025 Q2	$12.8M	Buy	+135,000	New	+$10M	0.66%	31

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

NWI Management's VRNA Position: Q4 2025 in Review

NWI Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 135,000 shares — an estimated $14.4M sold.

NWI Management first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $14.4M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

NWI Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
NWI Management sold 135,000 Verona Pharma shares in Q4 2025, an estimated $14.4M.
NWI Management first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
NWI Management's Verona Pharma position peaked at $14.4M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on NWI Management's 13F filing for Q4 2025, filed 17 Feb 2026.